Multidrug Resistance-associated Protein MRP1 Expression in Human Gliomas: Chemosensitization to Vincristine and Etoposide by Indomethacin in Human Glioma Cell Lines Overexpressing MRP1

Overview

Journal J Neurooncol

Publisher Springer

Date 2004 Mar 16

PMID 15015771

Citations 19

Authors

B Benyahia

S Huguet

X Decleves

K Mokhtari

E Criniere

J F Bernaudin

J M Scherrmann

J Y Delattre

Affiliations

Soon will be listed here.

Abstract

The 190 kDa multidrug resistance protein MRP1 is likely to be involved in the multidrug resistance phenotype of human gliomas. MRP1 expression was evaluated in surgical tumor samples from 17 patients with gliomas. In addition, the impact of the MRP's inhibitor, indomethacin, on the chemosensitivity to etoposide (VP16) and vincristine (VCR) of two glioblastoma cell lines expressing MRP1 (GL15 and 8MG) was investigated. When evaluated in tumor samples, MRP1 expression was observed in all of them with more than 90% of stained tumor cells in 14/15 high-grade gliomas. MRP1 was also strongly expressed at the membrane of the vascular endothelial cells in the same 14 tumor samples, suggesting that the permeability to anticancer drugs could be also limited across brain tumor vessels. At concentrations comprised between 5 and 50 microM, indomethacin significantly increased the cytotoxic effect of etoposide in both cell lines but it was more efficient in increasing the cytotoxicity of VCR on GL15 cells, as compared with 8MG cells. These results suggest that the association of indomethacin to VCR or etoposide could be of interest in the clinical management of gliomas.

Citing Articles

The impact of ATP-binding cassette transporters in the diseased brain: Context matters.

Baltira C, Aronica E, Elmquist W, Langer O, Loscher W, Sarkaria J Cell Rep Med. 2024; 5(6):101609.

PMID: 38897176 PMC: 11228798. DOI: 10.1016/j.xcrm.2024.101609.

The Relationship of Glutathione--Transferase and Multi-Drug Resistance-Related Protein 1 in Nitric Oxide (NO) Transport and Storage.

Russell T, Azad M, Richardson D Molecules. 2021; 26(19).

PMID: 34641326 PMC: 8510172. DOI: 10.3390/molecules26195784.

Suppression of Proliferation of Human Glioblastoma Cells by Combined Phosphodiesterase and Multidrug Resistance-Associated Protein 1 Inhibition.

Kopanitsa L, Kopanitsa M, Safitri D, Ladds G, Bailey D Int J Mol Sci. 2021; 22(18).

PMID: 34575827 PMC: 8471536. DOI: 10.3390/ijms22189665.

LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR-134/Myc/ABCC1 axis in glioma.

Wu C, Su J, Long W, Qin C, Wang X, Xiao K J Cell Mol Med. 2020; 24(20):12094-12106.

PMID: 32916774 PMC: 7579701. DOI: 10.1111/jcmm.15846.

ABC Transporters at the Blood-Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas.

Gomez-Zepeda D, Taghi M, Scherrmann J, Decleves X, Menet M Pharmaceutics. 2019; 12(1).

PMID: 31878061 PMC: 7022905. DOI: 10.3390/pharmaceutics12010020.

References

He J, Mokhtari K, Sanson M, Marie Y, Kujas M, Huguet S . Glioblastomas with an oligodendroglial component: a pathological and molecular study. J Neuropathol Exp Neurol. 2001; 60(9):863-71. DOI: 10.1093/jnen/60.9.863. View

Bocchini V, Casalone R, Collini P, Rebel G, Curto F . Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res. 1991; 265(1):73-81. DOI: 10.1007/BF00318141. View

Mohri M, Nitta H, Yamashita J . Expression of multidrug resistance-associated protein (MRP) in human gliomas. J Neurooncol. 2001; 49(2):105-15. DOI: 10.1023/a:1026528926482. View

Hikawa T, Mori T, Abe T, Hori S . The ability in adhesion and invasion of drug-resistant human glioma cells. J Exp Clin Cancer Res. 2001; 19(3):357-62. View

Haga S, Hinoshita E, Ikezaki K, Fukui M, Scheffer G, Uchiumi T . Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma. Jpn J Cancer Res. 2001; 92(2):211-9. PMC: 5926688. DOI: 10.1111/j.1349-7006.2001.tb01084.x. View

Bocchini V, Beccari T, Arcuri C, Bruyere L, Fages C, Tardy M . Glial fibrillary acidic protein and its encoding mRNA exhibit mosaic expression in a glioblastoma multiform cell line of clonal origin. Int J Dev Neurosci. 1993; 11(4):485-92. DOI: 10.1016/0736-5748(93)90022-6. View

Roller A, Bahr O, Streffer J, Winter S, Heneka M, Deininger M . Selective potentiation of drug cytotoxicity by NSAID in human glioma cells: the role of COX-1 and MRP. Biochem Biophys Res Commun. 1999; 259(3):600-5. DOI: 10.1006/bbrc.1999.0825. View

Kool M, van der Linden M, de Haas M, Baas F, Borst P . Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res. 1999; 59(1):175-82. View

Matsumoto T, Tani E, Kaba K, Shindo H, Miyaji K . Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg. 1991; 74(3):460-6. DOI: 10.3171/jns.1991.74.3.0460. View

10.

Perzelova A, Macikova I, Mraz P, Bizik I, Steno J . Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA. Neoplasma. 1998; 45(1):25-9. View

11.

Barrand M, Rhodes T, CENTER M, Twentyman P . Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. Eur J Cancer. 1993; 29A(3):408-15. DOI: 10.1016/0959-8049(93)90397-x. View

12.

Kool M, de Haas M, Scheffer G, Scheper R, Van Eijk M, Juijn J . Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997; 57(16):3537-47. View

13.

Tews D, Nissen A, Kulgen C, Gaumann A . Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors. J Neurooncol. 2001; 50(3):227-37. DOI: 10.1023/a:1006491405010. View

14.

Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M . Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer. 1994; 58(6):860-4. DOI: 10.1002/ijc.2910580619. View

15.

Wolff J, Trilling T, Molenkamp G, Egeler R, Jurgens H . Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol. 1999; 125(8-9):481-6. DOI: 10.1007/s004320050305. View

16.

Abe T, Mori T, Wakabayashi Y, Nakagawa M, Cole S, Koike K . Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J Neurooncol. 1999; 40(1):11-8. DOI: 10.1023/a:1005954406809. View

17.

Hipfner D, Gao M, Scheffer G, Scheper R, Deeley R, Cole S . Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP). Br J Cancer. 1998; 78(9):1134-40. PMC: 2063015. DOI: 10.1038/bjc.1998.642. View

18.

Abe T, Koike K, Ohga T, Kubo T, Wada M, Kohno K . Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Br J Cancer. 1995; 72(2):418-23. PMC: 2033970. DOI: 10.1038/bjc.1995.348. View

19.

Chamberlain M . Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide. Arch Neurol. 1997; 54(5):554-8. DOI: 10.1001/archneur.1997.00550170036012. View

20.

Decleves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I . Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int J Cancer. 2002; 98(2):173-80. DOI: 10.1002/ijc.10135. View